Citations

Clear

1820 citation(s) found for "Israel, E".

Pleural Port-A-Cath for Symptomatic Refractory Hepatic Hydrothorax in Nontransplant Liver Patients
眞雄, 鈴木, 惺, 松田, Paton, Alichia, Lara, Juan Camilo , Fernandez-Bussy, Sebastian, Majid, Adnan, Majid, Adnan , Alshabani, Khaled , Alshabani, Khaled, Rivera, Estefania, Paton, Alichia, Lara, Juan Camilo, Fernandez-Bussy, Sebastian, Majid, Adnan

Mayo Clinic

Annals of the American Thoracic Society | May 1, 2024 | Volume: 21 | Issue: 5 | Pages: 823-826

10.1513/annalsats.202306-580cc | PMID 38691004 Get It

Longitudinal Clinical Course of Participants With Asthma in Severe Asthma Research Program (SARP) Cohort
Phillips, Brenda R. , Gauthier, M., Israel, Elliot , Mauger, David T. , Ortega, Victor E. , Zein, Joe , Bleecker, Eugene R., Aronica, M.A., Comhair, Suzy , Denlinger, Loren C. , Erzurum, Serpil C. , Jarjour, Nizar N. , Moore, Wendy C. , Woodruff, Prescott G. , Sumino, Kaharu , Gauthier, M., Townsend, E.A., Castro, Mario , Fahy, John V. , Levy, Bruce David , Phipatanakul, Wanda , Wenzel, Sally E.

Mayo Clinic

C102. CLINICAL AND TRANSLATIONAL ADVANCES IN ASTHMA | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A6697-A6697

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6697 Get It

High Airway TSLP Levels in Asthma Associate With More Severe Disease and Multiple Biomarkers of Type 2 Inflammation
Khanna, Kritika , Tang, M., Jackson, Nathan D. , Charbit, Annabelle R. , Bleecker, Eugene R. , Comhair, S.A.A., Denlinger, Loren C. , Erzurum, Serpil C. , Hastie, Annette T. , Moore, W.C., Israel, Elliot , Jarjour, N.N., Mauger, David T. , Phillips, Brenda R. , Woodruff, Prescott G. , Fahy, J.V., Castro, Mario , Levy, Bruce David , Johansson, Mats W. , Sumino, Kaharu , Wenzel, Sally E. , Seibold, Max A.

Mayo Clinic

B16. NOVEL INSIGHTS INTO ASTHMA PATHOGENESIS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A3014-A3014

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3014 Get It

Temporal Trends in Critical Care Utilization and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Ochal, Domenic, Sklar, David P. , Litzow, Mark R. , Torghabeh, Mehrdad Hefazi, Yadav, Hemang , Heybati, Kiyan , Hogan, William J. , Alkhateeb, Hassan B. , Herasevich, Svetlana , Shah, Meera , Hefazi, Mehrdad , Durani, Urshila , Bauer, Philippe R. , Gajic, Ognjen

Mayo Clinic

A41. REVIEWING ALL THE SYSTEMS: ADVANCES IN NON-PULMONARY CRITICAL CARE | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1543-A1543

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1543 Get It

The role of vascularized bone grafting for scaphoid nonunions in adolescents
Israel, Jacqueline S. , Pulos, Nicholas , Pulos, Nicholas , Bishop, Allen T. , Shin, Alexander Y.

Mayo Clinic

Journal of Hand Surgery (European Volume) | April 25, 2024 | Volume: 49 | Issue: 9 | Pages: 1157-1159

10.1177/17531934241247279 | PMID 38663874 Get It

A total of 26 adolescent patients were treated for scaphoid nonunion with a vascularized bone graft from either the medial femoral condyle or dorsal distal radius. There was an 85% union incidence, improved carpal alignment and a low incidence of complications.
Abstract 9351: Are “All-Comer” Clinical Trials Representative of Contemporary Clinical Practice: A Linked Analysis of the Dual Antiplatelet Therapy (DAPT) Study and the National Cardiovascular Data Registry®
Yeh, Robert W. , Czarny, Matthew J. , Kim, Sunghee , Roe, Matthew T. , Holmes, David R. , Brindis, Ralph G. , Weaver, W. Douglas, Kereiakes, Dean J. , Normand, Sharon‐Lise T. , Mauri, Laura

Mayo Clinic

Circulation | April 23, 2024 | Volume: 128 | Issue: suppl_22 | Pages: No page available

10.1161/circ.128.suppl_22.a9351 Get It

Background: Randomized clinical trials are often criticized for not reflecting real-world practice. To understand the effect of site and patient selection on trial generalizability, we examined US patient and hospital participation within the Dual Antiplatelet Therapy (DAPT) Study, a broadly inclusive trial of PCI patients, using a linked analysis with the CathPCI Registry®. Methods: Within the CathPCI Registry, we identified patients undergoing PCI between September 1, 2009 and July 1, 2011 - the period of DAPT Study enrollment. We compared US patients enrolled in DAPT to CathPCI Registry patients meeting DAPT inclusion criteria. Characteristics of US DAPT sites were also compared to those of hospitals not participating in DAPT. Standardized differences (%) for all variables were estimated, with those greater than 10% considered significant. Results: Among 1,139,932 NCDR patients undergoing PCI, 748374 (65.7%) met the enrollment criteria for DAPT, and 23495 (2.1%) were enrolled. Enrolled patients were younger and had lower rates of prior stroke, CHF and peripheral vascular disease, but were similar with respect to race and gender compared with eligible patients (Table). Of the 1276 hospitals within the NCDR, 309 (24.2%) participated in DAPT. Hospital characteristics differed markedly, with DAPT-participating hospitals being larger (mean beds 468 vs. 311), more often located in urban settings (61.2% vs. 42.6%), more often affiliated with training programs (53.7% vs. 34.1%), and with higher annual PCI volumes (mean annual hospital volume 858 vs. 378 PCIs) compared with non-DAPT hospitals. Conclusions: While liberal inclusion criteria may allow randomized trials to better simulate “real-world” clinical practice, the process of site selection may encourage participation of higher volume, urban hospital settings. These findings are relevant to clinical trial interpretation and implementation of evidence-based practice throughout the healthcare system.
Abstract 5685: TGF-beta Signaling and Kruppel-like Factor 10 Regulate Bone Marrow-derived EPC Differentiation, Function, and Neovascularization
Wara, Akm Khyrul , Foo, ShiYin, Cao, Zhuoxiao, Subramaniam, Malayannan , Spelsberg, Thomas C, Icli, Basak , Cao, Zhuoxiao, Esen, Fehim , Spelsberg, Thomas C, Rosenzweig, Anthony , Feinberg, Mark W.

Mayo Clinic

Circulation | April 23, 2024 | Volume: 120 | Issue: suppl_18 | Pages: No page available

10.1161/circ.120.suppl_18.s1140-a Get It

Background: Endothelial progenitor cells (EPCs) may originate from the bone marrow and are capable of contributing to cardiovascular regeneration. However, the identities of these bone marrow cells and the signaling pathways that regulate their differentiation into functional EPCs remain poorly understood. Hematopoiesis consists of a cascade by which hematopoietic stem cells (HSCs) give rise to either a common myeloid progenitor (CMPs) or common lymphoid progenitor (CLPs). The CMP cells can give rise to either granulocyte-monocyte progenitors (GMPs) or megakaryocyte-erythrocyte progenitors (MEPs). Methods and Results: Herein, we identify that CMPs and GMPs preferentially differentiate into CD34+KDR+ EPCs as measured by FACS, uptake of DiIacLDL and U.lex Lectin, matrigel studies, and endothelial markers. Co-culture studies in matrigel demonstrate increased network formation and incorporation when HUVECs were co-incubated with CMPs and GMPs only. Treatment of CMPs or GMPs with IFN-g blocked EPC differentiation, whereas treatment with TGF-b1 potently induced EPC differentiation. Conversely, EPC formation was markedly impaired using blocking antibodies or TGF-b1 deficient CMPs or GMPs, whereas IFN-g deficient mice have increased EPC differentiation. Functionally, EPCs derived from CMPs and GMPs more potently adhered to fibronectin-coated plates, migrated faster in transwell Boyden chambers, and released VEGF nearly ~2 to 2.5-fold higher than EPCs from MEPs and HSCs. Finally, we identified that a TGF-b1-responsive Kruppel-like transcription factor, KLF10, as robustly expressed ~60-fold in EPCs derived from CMPs and GMPs, compared to hematopoietic progenitors lacking EPC markers. Consistently, KLF10−/− mice have marked defects in EPC differentiation (−23.6% vs. WT, P<0.002), TGF-b1 responsiveness (completedly abolished), and impaired blood flow recovery in response to hindlimb ischemia (−23.8% vs. WT, P<0.008), an effect associated with reduced levels of circulating EPCs (−28.2% vs. WT, P<0.05). Conclusion: Among bone marrow progenitors, a hierarchy exists for EPC differentiation. Targeting KLF10 may alter EPC differentiation from bone marrow-derived CMPs and GMPs and influence cardiovascular repair.